

The global market for Inhalation Preparation was valued at US$ 44450 million in the year 2024 and is projected to reach a revised size of US$ 63900 million by 2031, growing at a CAGR of 5.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhalation Preparation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalation Preparation.
The Inhalation Preparation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhalation Preparation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhalation Preparation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GSK
AstraZeneca
Boehringer-Ingelheim
CTTQ
Sphsine
Daphne Pharmaceutical
Xianju Pharmaceutical
Joincare Pharmaceutical
Hengrui Medicine
Purity Pharmaceutical
Jewim Pharmaceutical
CF PharmTech
Segment by Type
Metered Dose Inhalers (MDI)
Dry Powder Inhalation (DPI)
Nebules Inhalation Solution (NEB)
Spary
Segment by Application
Asthma
COPD
Pulmonary Hypertension Treatment
Inhalation Anesthesia
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalation Preparation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalation Preparation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Inhalation Preparation Market Overview
1.1 Product Definition
1.2 Inhalation Preparation by Type
1.2.1 Global Inhalation Preparation Market Value Comparison by Type (2024 VS 2031)
1.2.2 Metered Dose Inhalers (MDI)
1.2.3 Dry Powder Inhalation (DPI)
1.2.4 Nebules Inhalation Solution (NEB)
1.2.5 Spary
1.3 Inhalation Preparation by Application
1.3.1 Global Inhalation Preparation Market Value by Application (2024 VS 2031)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Pulmonary Hypertension Treatment
1.3.5 Inhalation Anesthesia
1.3.6 Others
1.4 Global Inhalation Preparation Market Size Estimates and Forecasts
1.4.1 Global Inhalation Preparation Revenue 2020-2031
1.4.2 Global Inhalation Preparation Sales 2020-2031
1.4.3 Global Inhalation Preparation Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inhalation Preparation Market Competition by Manufacturers
2.1 Global Inhalation Preparation Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inhalation Preparation Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inhalation Preparation Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inhalation Preparation, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhalation Preparation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhalation Preparation, Product Type & Application
2.7 Global Key Manufacturers of Inhalation Preparation, Date of Enter into This Industry
2.8 Global Inhalation Preparation Market Competitive Situation and Trends
2.8.1 Global Inhalation Preparation Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inhalation Preparation Players Market Share by Revenue
2.8.3 Global Inhalation Preparation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhalation Preparation Market Scenario by Region
3.1 Global Inhalation Preparation Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inhalation Preparation Sales by Region: 2020-2031
3.2.1 Global Inhalation Preparation Sales by Region: 2020-2025
3.2.2 Global Inhalation Preparation Sales by Region: 2026-2031
3.3 Global Inhalation Preparation Revenue by Region: 2020-2031
3.3.1 Global Inhalation Preparation Revenue by Region: 2020-2025
3.3.2 Global Inhalation Preparation Revenue by Region: 2026-2031
3.4 North America Inhalation Preparation Market Facts & Figures by Country
3.4.1 North America Inhalation Preparation Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inhalation Preparation Sales by Country (2020-2031)
3.4.3 North America Inhalation Preparation Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalation Preparation Market Facts & Figures by Country
3.5.1 Europe Inhalation Preparation Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inhalation Preparation Sales by Country (2020-2031)
3.5.3 Europe Inhalation Preparation Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalation Preparation Market Facts & Figures by Region
3.6.1 Asia Pacific Inhalation Preparation Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inhalation Preparation Sales by Region (2020-2031)
3.6.3 Asia Pacific Inhalation Preparation Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inhalation Preparation Market Facts & Figures by Country
3.7.1 Latin America Inhalation Preparation Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inhalation Preparation Sales by Country (2020-2031)
3.7.3 Latin America Inhalation Preparation Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhalation Preparation Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalation Preparation Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inhalation Preparation Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inhalation Preparation Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalation Preparation Sales by Type (2020-2031)
4.1.1 Global Inhalation Preparation Sales by Type (2020-2025)
4.1.2 Global Inhalation Preparation Sales by Type (2026-2031)
4.1.3 Global Inhalation Preparation Sales Market Share by Type (2020-2031)
4.2 Global Inhalation Preparation Revenue by Type (2020-2031)
4.2.1 Global Inhalation Preparation Revenue by Type (2020-2025)
4.2.2 Global Inhalation Preparation Revenue by Type (2026-2031)
4.2.3 Global Inhalation Preparation Revenue Market Share by Type (2020-2031)
4.3 Global Inhalation Preparation Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inhalation Preparation Sales by Application (2020-2031)
5.1.1 Global Inhalation Preparation Sales by Application (2020-2025)
5.1.2 Global Inhalation Preparation Sales by Application (2026-2031)
5.1.3 Global Inhalation Preparation Sales Market Share by Application (2020-2031)
5.2 Global Inhalation Preparation Revenue by Application (2020-2031)
5.2.1 Global Inhalation Preparation Revenue by Application (2020-2025)
5.2.2 Global Inhalation Preparation Revenue by Application (2026-2031)
5.2.3 Global Inhalation Preparation Revenue Market Share by Application (2020-2031)
5.3 Global Inhalation Preparation Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Inhalation Preparation Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Inhalation Preparation Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer-Ingelheim
6.3.1 Boehringer-Ingelheim Company Information
6.3.2 Boehringer-Ingelheim Description and Business Overview
6.3.3 Boehringer-Ingelheim Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer-Ingelheim Inhalation Preparation Product Portfolio
6.3.5 Boehringer-Ingelheim Recent Developments/Updates
6.4 CTTQ
6.4.1 CTTQ Company Information
6.4.2 CTTQ Description and Business Overview
6.4.3 CTTQ Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CTTQ Inhalation Preparation Product Portfolio
6.4.5 CTTQ Recent Developments/Updates
6.5 Sphsine
6.5.1 Sphsine Company Information
6.5.2 Sphsine Description and Business Overview
6.5.3 Sphsine Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sphsine Inhalation Preparation Product Portfolio
6.5.5 Sphsine Recent Developments/Updates
6.6 Daphne Pharmaceutical
6.6.1 Daphne Pharmaceutical Company Information
6.6.2 Daphne Pharmaceutical Description and Business Overview
6.6.3 Daphne Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Daphne Pharmaceutical Inhalation Preparation Product Portfolio
6.6.5 Daphne Pharmaceutical Recent Developments/Updates
6.7 Xianju Pharmaceutical
6.7.1 Xianju Pharmaceutical Company Information
6.7.2 Xianju Pharmaceutical Description and Business Overview
6.7.3 Xianju Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Xianju Pharmaceutical Inhalation Preparation Product Portfolio
6.7.5 Xianju Pharmaceutical Recent Developments/Updates
6.8 Joincare Pharmaceutical
6.8.1 Joincare Pharmaceutical Company Information
6.8.2 Joincare Pharmaceutical Description and Business Overview
6.8.3 Joincare Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Joincare Pharmaceutical Inhalation Preparation Product Portfolio
6.8.5 Joincare Pharmaceutical Recent Developments/Updates
6.9 Hengrui Medicine
6.9.1 Hengrui Medicine Company Information
6.9.2 Hengrui Medicine Description and Business Overview
6.9.3 Hengrui Medicine Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hengrui Medicine Inhalation Preparation Product Portfolio
6.9.5 Hengrui Medicine Recent Developments/Updates
6.10 Purity Pharmaceutical
6.10.1 Purity Pharmaceutical Company Information
6.10.2 Purity Pharmaceutical Description and Business Overview
6.10.3 Purity Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Purity Pharmaceutical Inhalation Preparation Product Portfolio
6.10.5 Purity Pharmaceutical Recent Developments/Updates
6.11 Jewim Pharmaceutical
6.11.1 Jewim Pharmaceutical Company Information
6.11.2 Jewim Pharmaceutical Description and Business Overview
6.11.3 Jewim Pharmaceutical Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jewim Pharmaceutical Inhalation Preparation Product Portfolio
6.11.5 Jewim Pharmaceutical Recent Developments/Updates
6.12 CF PharmTech
6.12.1 CF PharmTech Company Information
6.12.2 CF PharmTech Description and Business Overview
6.12.3 CF PharmTech Inhalation Preparation Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CF PharmTech Inhalation Preparation Product Portfolio
6.12.5 CF PharmTech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalation Preparation Industry Chain Analysis
7.2 Inhalation Preparation Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalation Preparation Production Mode & Process Analysis
7.4 Inhalation Preparation Sales and Marketing
7.4.1 Inhalation Preparation Sales Channels
7.4.2 Inhalation Preparation Distributors
7.5 Inhalation Preparation Customer Analysis
8 Inhalation Preparation Market Dynamics
8.1 Inhalation Preparation Industry Trends
8.2 Inhalation Preparation Market Drivers
8.3 Inhalation Preparation Market Challenges
8.4 Inhalation Preparation Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
GSK
AstraZeneca
Boehringer-Ingelheim
CTTQ
Sphsine
Daphne Pharmaceutical
Xianju Pharmaceutical
Joincare Pharmaceutical
Hengrui Medicine
Purity Pharmaceutical
Jewim Pharmaceutical
CF PharmTech
Ìý
Ìý
*If Applicable.